Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kinetics of Elimination of Methotrexate and Its Major Metabolite 7-OH-methotrexate for Observant Patients
NCT03852888Completed
- Sponsor
- CHU de Reims
- Start
- Nov 2018
- Primary completion
- Nov 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of methotrexate in rheumatoid arthritis (RA), sponsored by CHU de Reims. Primary endpoint: Urinary concentration of methotrexate and its major metabolite 7-OH-methotrexate at Day 8. Started Nov 2018; status: completed.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03852888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03852888.